Recommendations for the Treatment of Valvular Heart Disease | ACHD Guideline | JACC

Learn more about the ACHD guideline in JACC's February 24 issue. In our latest interview, JACC Consultant Yonatan Buber, MD, FACC joins author Patrick T O'Gara, MD, MACC to discuss key insights from the 2025 Adult Congenital Heart Disease guidelines and how they intersect with the 2020 ACC/AHA Valvular Heart Disease guidelines. The conversation highlights the importance of multidisciplinary, shared decision-making for younger ACHD patients, particularly when valve interventions have lifelong implications. They also explore how clinicians can thoughtfully navigate between guidelines, balance limited evidence with expert consensus, and refer patients to experienced ACHD centers to optimize long-term outcomes.